InsidersTradesSigma
Follow the Biovica International AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Biovica International AB has logged 3 public disclosures. Market capitalisation: €105.1m. The latest transaction was filed on 29 June 2026 (Purchase). Among the most active insiders: Theis Kipling. Every trade is accessible without an account.
Analysts rate Biovica International AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 0.60.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Biovica International AB is a company focused on developing diagnostic tests for cancer. It is listed on the Stockholm Stock Exchange (XSTO).